Menveo vaccine VL 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FAYAR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,382
Award facts
- Contract value 100% obligated
- $16,381.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,381.98 delivery order to Amerisourcebergen Drug Corp on April 10, 2026, for Menveo vaccine (VL 10S).
The order is issued under the company's DLA Troop Support Medical indefinite delivery contract (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price structure with an ultimate completion date of April 13, 2026.
Quick answers
Who was awarded contract SPE2DR26FAYAR?
SPE2DR26FAYAR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 10, 2026.
How much is contract SPE2DR26FAYAR worth?
The government has obligated $16,382 on SPE2DR26FAYAR.
Is contract SPE2DR26FAYAR an order under another contract?
Yes. SPE2DR26FAYAR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAYAR competed?
The extent of competition for SPE2DR26FAYAR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award